1. |
Galano JM, Lee JC, Gladine C, et al. Non-enzymatic cyclic oxygenated metabolites of adrenic, docosahexaenoic, eicosapentaenoic and alpha-linolenic acids; bioactivities and potential use as biomarkers[J]. Biochim Biophys Acta, 2015, 1851(4): 446-455. DOI: 10.1016/j.bbalip.2014.11.004.
|
2. |
Brahmbhatt V, Oliveira M, Briand M, et al. Protective effects of dietary EPA and DHA on ischemia-reperfusion-induced intestinal stress[J]. J Nutr Biochem, 2013, 24(1): 104-111. DOI: 10.1016/j.jnutbio.2012.02.014.
|
3. |
Kromhout D, Yasuda S, Geleijinse JM, et al. Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work[J]. Eur Heart J, 2012, 33(4): 436-443. DOI: 10.1093/eurheartj/ehr362.
|
4. |
Nettleton JA, Katz R. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review[J]. J Am Diet Assoc, 2005, 105(3): 428-440. DOI: 10.1016/j.jada.2004.11.029.
|
5. |
Sterescu AE, Rousseau-Harsany E, farrell C, et al. The potential efficacy of omega-3 fatty acids as anti-angiogenic agents in benign vascular tumors of infancy[J]. Med Hypotheses, 2006, 66(6): 1121-1124. DOI: 10.1016/j.mehy.2005.12.040.
|
6. |
Serini S, Piccioni E, Calviello G. Dietary n-3 PUFA vascular targeting and the prevention of tumor growth and age-related macular degeneration[J]. Curr Med Chem, 2009, 16(34): 4511-4526.
|
7. |
Soderberg M, Edlund C, Kristensson K, et al. Lipid compositions of different regions of the human brain during aging[J]. J Neurochem, 1990, 54(2): 415-423.
|
8. |
Soderberg M, Edlund C, Kristensson K, et al. Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease[J]. Lipids, 1991, 26(6): 421-425.
|
9. |
McGahon MK, Zhang X, Scholfield CN, et al. Selective downregulation of the BKbeta1 subunit in diabetic arteriolar myocytes[J]. Channels (Austin), 2007, 1(3): 141-143.
|
10. |
Peng G, Xu J, Liu R, et al. Isolation, culture and identification of pulmonary arterial smooth muscle cells from rat distal pulmonary arteries[J/OL]. Cytotechnology, 2017, 2017: E1[201703-21]. . DOI: 10.1007/s10616-017-0081-8. [published online ahead of print].
|
11. |
Saleh SN, Albert AP, Peppiatt-Wildman CM, et al. Diverse properties of store-operated TRPC channels activated by protein kinase C in vascular myocytes[J]. J Physiol, 2008, 586(10): 2463-2476. DOI: 10.1113/jphysiol.2008.152157.
|
12. |
Ghatta S, Nimmagadda D, Xu X, et al. Large-conductance, calcium-activated potassium channels: structural and functional implications[J]. Pharmacol Ther, 2006, 110(1): 103-116. DOI: 10.1016/j.pharmthera.2005.10.007.
|
13. |
Hou S, Heinemann S, Hoshi T. Modulation of BKCa channel gating by endogenous signaling molecules[J]. Physiology (Bethesda), 2009, 24: 26-35. DOI: 10.1152/physiol.00032.2008.
|
14. |
Torres YP, Granados ST, Latorre R. Pharmacological consequences of the coexpression of BK channel alpha and auxiliary beta subunits[J]. Front Physiol, 2014, 5: 383. DOI: 10.3389/fphys.2014.00383.
|
15. |
Dopico AM, Bukiya AN. Lipid regulation of BK channel function[J]. Front Physiol, 2014, 5: 312. DOI: 10.3389/fphys.2014.00312.
|
16. |
Aires V, Hichami A, Filomenko R, et al. Docosahexaenoic acid induces increases in [Ca2+]i via inositol 1, 4, 5-triphosphate production and activates protein kinase C gamma and-delta via phosphatidylserine binding site: implication in apoptosis in U937 cells[J]. Mol Pharmacol, 2007, 72(6): 1545-1556. DOI: 10.1124/mol.107.039792.
|